FrancophonIA/ELRC3.0 huggingface dataset:
English: Concomitant administration of rivastigmine with commonly prescribed medicinal products, such as antacids, antiemetics, antidiabetics, centrally acting antihypertensives, calcium channel blockers, inotropic agents, antianginals, non-steroidal anti-inflammatory agents, oestrogens, analgesics, benzodiazepines and antihistamines, was not associated with an alteration in the kinetics of rivastigmine or an increased risk of clinically relevant untoward effects.
Danish: Eksempler på disse lægemidler er: antacida, antiemetika, antidiabetika, centralt virkende antihypertensiva, calciumantagonister, inotrope midler, midler mod angina pectoris, non-steroide antiinflammatoriske stoffer, østrogener, analgetika, benzodiazepiner og antihistaminer.
English: • The signs of Parkinson's disease get worse - such as tremor, stiffness and shuffling
Danish: Symptomer på Parkinsons sygdom bliver værre- såsom rysten, stivhed og slæben
English: Somnolence
Danish: Søvnbesvær
English: Urinary incontinence General disorders and administration site conditions Common
Danish: Urininkontinens Almene symptomer og reaktioner på administrationsstedet Almindelig
English: Where to apply your Prometax transdermal patch
Danish: Placering af dit Prometax depotplaster
English: - if you have, or have ever had, impaired liver function.
Danish: - hvis du har eller har haft nedsat leverfunktion.
English: - Prometax 3.0 mg hard capsules, which contain an off-white to slightly yellow powder, have an orange cap and orange body, with a red imprint “ENA 713 3 mg” on the body.
Danish: - Prometax 3,0 mg hårde kapsler, som indeholder et råhvidt til svagt gulligt pulver, har en orange hætte og en orange skal, med ” ENA 713 3 mg”, der er præget med rødt på kapselskallen.
English: - Prometax 4.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and red body, with a white imprint “ENA 713 4,5 mg” on the body.
Danish: - Prometax 4,5 mg hårde kapsler, som indeholder et råhvidt til svagt gulligt pulver, har en rød hætte og en rød skal, med ” ENA 713 4,5 mg”, der er præget med hvidt på kapselskallen.
English: - Prometax 6.0 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and orange body, with a red imprint “ENA 713 6 mg” on the body.
Danish: - Prometax 6,0 mg hårde kapsler, som indeholder et råhvidt til svagt gulligt pulver, har en rød hætte og en orange skal, med ” ENA 713 6 mg”, der er præget med rødt på kapselskallen.
English: Salivary hypersecretion
Danish: Øget spytsekretion
English: Gastrointestinal disorders Common
Danish: Gastrointestinale gener
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 1.5 mg rivastigmine.
Danish: Hver kapsel indeholder rivastigminhydrogentartrat svarende til 1,5 mg rivastigmin.
English: Hepatobiliary disorders Not known
Danish: Ikke almindelig Bradykardi Ikke kendt
English: • Uneven heart rate (e.g. fast heart rate)
Danish: • Uregelmæssig hjerterytme (puls)
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 6.0 mg rivastigmine.
Danish: Hver kapsel indeholder rivastigminhydrogentartrat svarende til 6,0 mg rivastigmin.
English: Uncommon (may affect up to 1 in 100 people) • Hyperactivity (high level of activity, restlessness)
Danish: Ikke almindelig (kan forekomme hos op til 1 ud af 100 patienter) Uregelmæssig hjerterytme (puls), dårlig kontrol over bevægelser
English: Particular caution should be exercised in titrating these patients (see sections 4.4 and 5.2).
Danish: Der skal udvises særlig opmærksomhed ved titrering af dosis hos disse patienter (se pkt.
English: Prometax 6.0 mg hard capsules
Danish: Prometax 6,0 mg hårde kapsler
English: Prometax 1.5 mg hard capsules
Danish: Prometax 1,5 mg hårde kapsler
English: In vitro, this metabolite shows minimal inhibition of acetylcholinesterase
Danish: Denne metabolit viser in vitro minimal hæmning af acetylkolinesterase (<10%).
English: Each ml contains 2 mg rivastigmine present as rivastigmine hydrogen tartrate.
Danish: 1 ml indeholder 2 mg rivastigmin som rivastigminhydrogentartrat.
English: • Uneven heartbeat and poor control of movements Other side effects seen with Prometax transdermal patches and which may occur with the hard capsules:
Danish: Andre bivirkninger, der er set med Prometax depotplaster, og som kan forekomme ved brug af hårde kapsler:
English: Take off the previous patch before putting ONE new patch on.
Danish: • Fjern det gamle plaster, før du påsætter ÉT nyt plaster.
English: Prometax 3.0 mg hard capsules
Danish: Prometax 3,0 mg hårde kapsler
English: 1 transdermal patch per sachet
Danish: 1 depotplaster pr. brev
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 4.5 mg rivastigmine.
Danish: Hver kapsel indeholder rivastigminhydrogentartrat svarende til 4,5 mg rivastigmin.
English: Prometax 1.5 mg hard capsules rivastigmine
Danish: Prometax 1,5 mg hårde kapsler rivastigmin
English: 1 capsule contains 1.5 mg rivastigmine present as rivastigmine hydrogen tartrate.
Danish: 1 kapsel indeholder 1,5 mg rivastigmin som rivastigminhydrogentartrat.
English: Prometax 4.6 mg/24 h transdermal patch rivastigmine
Danish: Prometax 4,6 mg/24 timer depotplaster rivastigmin
English: Prometax 4.5 mg hard capsules
Danish: Prometax 4,5 mg hårde kapsler
English: Prometax 3.0 mg hard capsules rivastigmine
Danish: Prometax 3,0 mg hårde kapsler rivastigmin
English: 1 capsule contains 6.0 mg rivastigmine present as rivastigmine hydrogen tartrate.
Danish: 1 kapsel indeholder 6,0 mg rivastigmin som rivastigminhydrogentartrat.
English: Prometax 6.0 mg hard capsules rivastigmine
Danish: Prometax 6,0 mg hårde kapsler rivastigmin
English: Prometax 13.3 mg/24 h transdermal patch rivastigmine
Danish: Prometax 13,3 mg/24 timer depotplaster rivastigmin
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 3.0 mg rivastigmine.
Danish: Hver kapsel indeholder rivastigminhydrogentartrat svarende til 3,0 mg rivastigmin.
English: Elevated liver function tests
Danish: Hepatitis, forhøjede leverfunktionstest
English: Prometax 9.5 mg/24 h transdermal patch rivastigmine
Danish: Prometax 9,5 mg/24 timer depotplaster rivastigmin
English: Off-white to slightly yellow powder in a capsule with red cap and red body, with white imprint “ENA 713 4,5 mg” on body.
Danish: Råhvidt til svagt gulligt pulver i en kapsel med rød hætte og rød skal, med ”ENA 713 4,5 mg” præget med hvidt på kapselskallen.
English: • Trembling or feeling confused
Danish: Rysten eller følelse af forvirring Øget svedtendens
English: 9.5 mg/24 h transdermal patches.
Danish: 9,5 mg/24 timer depotplastre.
English: Children and adolescents There is no relevant use of Prometax in the paediatric population in the treatment of Alzheimer's disease.
Danish: Der er ingen relevante indikationer for brug af Prometax til behandling af Alzheimers sygdom hos børn og teenagere.
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Danish: Brug af anden medicin sammen med Prometax Fortæl altid lægen eller apotekspersonalet, hvis du bruger anden medicin eller har gjort det for nylig.
English: Off-white to slightly yellow powder in a capsule with yellow cap and yellow body, with red imprint “ENA 713 1,5 mg” on body.
Danish: Råhvidt til svagt gulligt pulver i en kapsel med gul hætte og gul skal, med ”ENA 713 1,5 mg” præget med rødt på kapselskallen.
English: Filling the syringe
Danish: Sår på tarmen
English: Off-white to slightly yellow powder in a capsule with orange cap and orange body, with red imprint “ENA 713 3 mg” on body.
Danish: Råhvidt til svagt gulligt pulver i en kapsel med orange hætte og orange skal, med ”ENA 713 3 mg” præget med rødt på kapselskallen.
English: 1 capsule contains 3.0 mg rivastigmine present as rivastigmine hydrogen tartrate.
Danish: 1 kapsel indeholder 3,0 mg rivastigmin som rivastigminhydrogentartrat.
English: 1 capsule contains 4.5 mg rivastigmine present as rivastigmine hydrogen tartrate.
Danish: 1 kapsel indeholder 4,5 mg rivastigmin som rivastigminhydrogentartrat.
English: Rare (may affect up to 1 in 1,000 people)
Danish: Sjælden (kan forekomme hos op til 1 ud af 1.000 patienter) Krampeanfald
English: Prometax 4.5 mg hard capsules rivastigmine
Danish: Prometax 4,5 mg hårde kapsler rivastigmin
English: Off-white to slightly yellow powder in a capsule with red cap and orange body, with red imprint “ENA 713 6 mg” on body.
Danish: Råhvidt til svagt gulligt pulver i en kapsel med rød hætte og orange skal, med ”ENA 713 6 mg” præget med rødt på kapselskallen.
English: • Anxiety
Danish: • Rastløshed
English: What Prometax is and what it is used for What you need to know before you use Prometax How to use Prometax
Danish: Det skal du vide, før du begynder at bruge Prometax Sådan skal du bruge Prometax Bivirkninger
English: Prometax transdermal patches 9.5 mg/24 h
Danish: Prometax depotplastre 9,5 mg/24 t
English: Each transdermal patch of 5 cm contains 9 mg of rivastigmine.
Danish: Hvert depotplaster på 5 cm indeholder
English: If the oral dose of 9 mg/day has not been stable and well tolerated, a switch to 4.6 mg/24 h transdermal patches is recommended.
Danish: Hvis den orale dosis på 9 mg/dag ikke er stabil og veltolereret,
English: Other medicines and Prometax
Danish: ADAS-C og Prometax
English: • The recommended usual daily dose is Prometax 9.5 mg/24 h. If well tolerated, the treating physician may consider increasing the dose to 13.3 mg/24 h.
Danish: • Den anbefalede sædvanlige daglige dosis er Prometax 9,5 mg/24 timer.
English: EU/1/98/092/025 60 transdermal patches (sachet: paper/PET/alu/PAN) EU/1/98/092/026 90 transdermal patches (sachet: paper/PET/alu/PAN) EU/1/98/092/037 60 transdermal patches (sachet: paper/PET/PE/alu/PA) EU/1/98/092/038 90 transdermal patches (sachet: paper/PET/PE/alu/PA)
Danish: EU/1/98/092/025 60 depotplastre (brev: papir/PET/alu/PAN) EU/1/98/092/026 90 depotplastre (brev: papir/PET/alu/PAN) EU/1/98/092/037 60 depotplastre (brev: papir/PET/PE/alu/PA) EU/1/98/092/038 90 depotplastre (brev: papir/PET/PE/alu/PA)
English: EU/1/98/092/029 60 transdermal patches (sachet: paper/PET/alu/PAN) EU/1/98/092/030 90 transdermal patches (sachet: paper/PET/alu/PAN) EU/1/98/092/041 60 transdermal patches (sachet: paper/PET/PE/alu/PA) EU/1/98/092/042 90 transdermal patches (sachet: paper/PET/PE/alu/PA)
Danish: EU/1/98/092/029 60 depotplastre (brev: papir/PET/alu/PAN) EU/1/98/092/030 90 depotplastre (brev: papir/PET/alu/PAN) EU/1/98/092/041 60 depotplastre (brev: papir/PET/PE/alu/PA) EU/1/98/092/042 90 depotplastre (brev: papir/PET/PE/alu/PA)
English: Very rare (may affect up to 1 in 10,000 people)
Danish: Meget sjælden (kan forekomme hos op til 1 ud af 10.000 patienter) Forhøjet blodtryk
English: Prometax 9.5 mg/24 h transdermal patch
Danish: Prometax 9,5 mg/24 timer depotplaster
English: • Uneven heartbeat and poor control of movements Other side effects seen with Prometax transdermal patches and which may occur with the oral solution:
Danish: Andre bivirkninger, der er set med Prometax depotplaster, og som kan forekomme ved brug af oral opløsning:
English: Prometax 4.6 mg/24 h transdermal patch
Danish: Prometax 4,6 mg/24 timer depotplaster
English: Prometax 13.3 mg/24 h transdermal patch
Danish: Prometax 13,3 mg/24 timer depotplaster
English: Headache, syncope, dizziness
Danish: Udslæt, kløe
English: Gastric and duodenal ulcers
Danish: Nyrer og urinveje Almindelig
English: What Prometax looks like and contents of the pack Each transdermal patch is a thin patch consisting of three layers.
Danish: Hvert depotplaster er et tyndt plaster, som består af tre lag.
English: EU/1/98/092/027 7 transdermal patches (sachet: paper/PET/alu/PAN) EU/1/98/092/028 30 transdermal patches (sachet: paper/PET/alu/PAN) EU/1/98/092/039 7 transdermal patches (sachet: paper/PET/PE/alu/PA) EU/1/98/092/040 30 transdermal patches (sachet: paper/PET/PE/alu/PA)
Danish: EU/1/98/092/027 7 depotplastre (brev: papir/PET/alu/PAN) EU/1/98/092/028 30 depotplastre (brev: papir/PET/alu/PAN) EU/1/98/092/039 7 depotplastre (brev: papir/PET/PE/alu/PA) EU/1/98/092/040 30 depotplastre (brev: papir/PET/PE/alu/PA)
English: EU/1/98/092/023 7 transdermal patches (sachet: paper/PET/alu/PAN) EU/1/98/092/024 30 transdermal patches (sachet: paper/PET/alu/PAN) EU/1/98/092/035 7 transdermal patches (sachet: paper/PET/PE/alu/PA) EU/1/98/092/036 30 transdermal patches (sachet: paper/PET/PE/alu/PA)
Danish: EU/1/98/092/023 7 depotplastre (brev: papir/PET/alu/PAN) EU/1/98/092/024 30 depotplastre (brev: papir/PET/alu/PAN) EU/1/98/092/035 7 depotplastre (brev: papir/PET/PE/alu/PA) EU/1/98/092/036 30 depotplastre (brev: papir/PET/PE/alu/PA)
English: Malaise
Danish: Rastløshed
English: EU/1/98/092/021 60 transdermal patches (sachet: paper/PET/alu/PAN) EU/1/98/092/022 90 transdermal patches (sachet: paper/PET/alu/PAN) EU/1/98/092/033 60 transdermal patches (sachet: paper/PET/PE/alu/PA) EU/1/98/092/034 90 transdermal patches (sachet: paper/PET/PE/alu/PA)
Danish: EU/1/98/092/021 60 depotplastre (brev: papir/PET/alu/PAN) EU/1/98/092/022 90 depotplastre (brev: papir/PET/alu/PAN) EU/1/98/092/033 60 depotplastre (brev: papir/PET/PE/alu/PA) EU/1/98/092/034 90 depotplastre (brev: papir/PET/PE/alu/PA)
English: EU/1/98/092/019 7 transdermal patches (sachet: paper/PET/alu/PAN) EU/1/98/092/020 30 transdermal patches (sachet: paper/PET/alu/PAN) EU/1/98/092/031 7 transdermal patches (sachet: paper/PET/PE/alu/PA) EU/1/98/092/032 30 transdermal patches (sachet: paper/PET/PE/alu/PA)
Danish: EU/1/98/092/019 7 depotplastre (brev: papir/PET/alu/PAN) EU/1/98/092/020 30 depotplastre (brev: papir/PET/alu/PAN) EU/1/98/092/031 7 depotplastre (brev: papir/PET/PE/alu/PA) EU/1/98/092/032 30 depotplastre (brev: papir/PET/PE/alu/PA)
English: FOLDING BOX
Danish: DBuge 48
English: Each transdermal patch of 15 cm contains 27 mg of rivastigmine.
Danish: Hvert depotplaster på 15 cm indeholder
English: Skin irritation
Danish: Muskelstivhed
English: What Prometax is and what it is used for What you need to know before you take Prometax How to take Prometax
Danish: Det skal du vide, før du begynder at tage Prometax Sådan skal du tage Prometax Bivirkninger
English: • Aggression
Danish: • Produktresumé
English: Urinary tract infection Metabolism and nutrition disorders Common
Danish: Anoreksi, nedsat appetit Ikke almindelig Dehydrering Psykiske forstyrrelser Almindelig
English: Gait abnormality
Danish: Abnorm måde at gå på
English: It is not for use in women and must not be given to women who are or who may be pregnant.
Danish: Det er endvidere ikke beregnet til kvinder og må ikke gives til kvinder, som er eller kan være gravide.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Zytiga on 5 September 2011.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Zytiga den 5. september 2011.
English: The full EPAR for Zytiga can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Danish: Den fuldstændige EPAR for Zytiga findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: Treatment may be resumed at a reduced dose if liver function returns to normal.
Danish: Behandlingen kan genoptages med en lavere dosis, hvis leverfunktionen bliver normal igen.
English: This is a summary of the European public assessment report (EPAR) for Zytiga.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Zytiga.
English: Other information about Zytiga
Danish: Andre oplysninger om Zytiga
English: The recommended dose of Zytiga is 1,000 mg taken once a day at least two hours after eating and at least one hour before further food.
Danish: Den anbefalede dosis af Zytiga er 1 000 mg én gang dagligt mindst to timer efter, at man har spist, og mindst en time før man spiser igen.
English: Zytiga is available as tablets (250 and 500 mg) and can only be obtained with a prescription.
Danish: Zytiga fås som tabletter (250 og 500 mg) og udleveres kun efter recept.
English: Zytiga must not be used in patients with severely reduced liver function.
Danish: Zytiga må ikke anvendes hos patienter med svært nedsat leverfunktion.
English: In the studies, patients were also treated with prednisone or prednisolone.
Danish: I undersøgelserne blev patienterne også behandlet med prednison eller prednisolon.
English: Zytiga was compared with placebo (a dummy treatment) in three main studies.
Danish: Zytiga blev sammenlignet med placebo (en virkningsløs behandling) i tre hovedundersøgelser.
English: If patients develop liver problems treatment should be stopped.
Danish: Hvis patienter udvikler leverproblemer, skal behandlingen afbrydes.
English: Zytiga is well tolerated and its risks are considered manageable.
Danish: Zytiga tåles godt, og risiciene anses for at kunne håndteres.
English: The main measure of effectiveness was how long patients lived without their disease getting worse.
Danish: Behandlingens virkning blev hovedsagelig bedømt på, hvor længe patienterne levede, uden at sygdommen forværredes.
English: What measures are being taken to ensure the safe and effective use of Zytiga?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Zytiga?
English: The Agency noted that Zytiga in combination with prednisone or prednisolone has been shown to either delay progression of the disease or improve survival compared with placebo.
Danish: Agenturet bemærkede, at Zytiga i kombination med prednison eller prednisolon har vist sig enten at forsinke sygdommens progression eller at forbedre overlevelsen i forhold til placebo.
English: • when medical or surgical castration and chemotherapy containing docetaxel have not worked or no longer work.
Danish: • når medicinsk eller kirurgisk kastration og kemoterapi indeholdende docetaxel ikke har virket eller ikke længere virker.
English: Zytiga abiraterone acetate
Danish: Zytiga abirateronacetat
English: Why is Zytiga approved?
Danish: Hvorfor blev Zytiga godkendt?
English: Zytiga is a medicine used to treat cancer of the prostate (a gland of the male reproductive system) in adult men when the cancer is metastatic (has spread to other parts of the body).
Danish: Zytiga er et lægemiddel, der anvendes til behandling af kræft i prostata (en kirtel i det mandlige forplantningssystem) hos voksne mænd, når kræften er metastatisk (har bredt sig til andre dele af kroppen).
English: Abiraterone does this by blocking an enzyme called CYP17 found in the testes and elsewhere in the body.
Danish: Det sker ved, at abirateron blokerer et enzym kaldet CYP17, som findes i testiklerne og andre steder i kroppen.
English: One study involved 1,209 patients with newly diagnosed, high-risk, hormone-sensitive, metastatic prostate cancer.
Danish: En undersøgelse omfattede 1 209 patienter med nydiagnosticeret, højrisiko, hormon-sensitiv, metastatisk prostatakræft.
English: The European Medicines Agency decided that Zytiga's benefits are greater than its risks and recommended that it be approved for use in the EU.
Danish: Det Europæiske Lægemiddelagentur konkluderede, at fordelene ved Zytiga opvejer risiciene, og anbefalede, at det godkendes til anvendelse i EU.
English: What is Zytiga and what is it used for?
Danish: Hvad er Zytiga, og hvad anvendes det til?
English: Other important side effects include heart problems, liver problems, fractures and allergic alveolitis (a lung reaction causing cough and shortness of breath).
Danish: Andre vigtige bivirkninger er hjerteproblemer, leverproblemer, frakturer og allergisk alveolitis (en lungereaktion, som medfører hoste og kortåndethed).
English: It is not intended to provide practical advice on how to use Zytiga.
Danish: Det er ikke en praktisk vejledning i, hvordan Zytiga bør anvendes.
English: Zytiga is used together with the medicines prednisone or prednisolone in the following situations:
Danish: Zytiga anvendes sammen lægemidlerne prednison eller prednisolon i følgende situationer:
English: The second study involved 1,088 men with metastatic prostate cancer who had either no symptoms or only mild symptoms of the disease and for whom castration treatment had not worked or had stopped working.
Danish: Den anden undersøgelse omfattede 1 088 mænd med metastatisk prostatakræft, som enten ingen symptomer havde eller kun havde lette symptomer på sygdommen, og hos hvem kastrationsbehandling ikke havde virket eller var holdt op med at virke.
English: In a third study involving 1,195 men with metastatic prostate cancer whose disease had got worse despite surgical or medical castration treatment and chemotherapy with docetaxel, the main measure of effectiveness was overall survival (how long the patients lived).
Danish: I en tredje undersøgelse, der omfattede 1 195 mænd med metastatisk prostatakræft, hvis sygdom var blevet værre på trods af kirurgisk eller medicinsk kastrationsbehandling og kemoterapi med docetaxel blev virkningen hovedsagelig målt på den samlede overlevelse (hvor længe patienterne levede).
English: For more information about treatment with Zytiga, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Zytiga kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: Because the cancer needs a supply of testosterone to survive and grow, by reducing the production of testosterone, Zytiga may slow the growth of the prostate cancer.
Danish: Da kræften skal have tilført testosteron for at overleve og vokse, kan Zytiga forsinke prostatakræftens udvikling ved at reducere produktionen af testosteron.
English: • when medical castration (using medicines to stop the production of male hormones) with an androgen deprivation therapy has not worked or no longer works in men who have either no symptoms or only mild symptoms of the disease, and who do not yet need chemotherapy (cancer medicines);
Danish: • når medicinsk kastration (hvor man stopper produktionen af mandlige kønshormoner med en behandling kaldet androgen deprivationsbehandling ikke har virket eller ikke længere virker hos mænd, som enten ingen symptomer har, eller som kun har lette symptomer på sygdommen, og som endnu ikke har behov for kemoterapi (lægemidler mod kræft)
English: What are the risks associated with Zytiga?
Danish: Hvilke risici er der forbundet med Zytiga?
English: The most common side effects with Zytiga (seen in more than 1 patient in 10) are urinary tract infection, hypokalaemia (low blood potassium levels), high blood pressure, peripheral oedema (swelling of the limbs due to fluid retention) and increases in liver enzymes.
Danish: De hyppigste bivirkninger ved Zytiga (som optræder hos mere end 1 ud af 10 patienter) er urinvejsinfektion, hypokaliæmi (lavt kaliumindhold i blodet), højt blodtryk, perifere ødemer (hævelse af lemmerne på grund af væskeophobning) og forhøjet antal leverenzymer.
English: Zytiga contains the active substance abiraterone acetate.
Danish: Zytiga indeholder det aktive stof abirateronacetat.
English: For practical information about using Zytiga, patients should read the package leaflet or contact their doctor or pharmacist.
Danish: Hvis du ønsker praktisk vejledning om anvendelsen af Zytiga, kan du læse indlægssedlen eller kontakte din læge eller dit apotek.
English: For the full list of all side effects reported with Zytiga, see the package leaflet.
Danish: Den fuldstændige liste over indberettede bivirkninger ved Zytiga fremgår af indlægssedlen.
English: Patients treated with Zytiga lived for just under 15 months from the start of treatment compared with just under 11 months for patients given placebo.
Danish: De patienter, som var blevet behandlet med Zytiga, levede i lige under 15 måneder fra starten af behandlingen, sammenlignet med lige under 11 måneder for de patienter, som havde fået placebo.
English: How is Zytiga used?
Danish: Hvordan anvendes Zytiga?